What is Ado-Trastuzumab Emtansine used for?

Ado-trastuzumab emtansine is used as a single agent to treat HER2-positive, metastatic breast cancer who previously received trastuzumab and a taxane, separately or in combination. Patients should have either:

  • Received prior therapy for metastatic disease, or
  • Developed disease recurrence during or within 6 months of completely adjuvant therapy

For procurement of Ado-trastuzumab emtansine brands in India, sold by Indian Drug Manufacturer. Please call at M: +91 9811747774 or Email Us to know more details about the medicine and its cost price in India.
ado-trastuzumab emtansine for injection

Get In Touch

ado-trastuzumab emtansine suppliers & wholesalers in India

Head Office of Indian Pharma Network (IPN) is in New Delhi, INDIA.
For Indian Patients kadcyla and Herclon can be made available to patients, doctors and hospitals at Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow and Pune and other cities in India.
For overseas patient kadcyla and Herclon brands in India can be also made available to overseas patients, doctors and hospitals. The order will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

Ado-trastuzumab emtansine Brands In India

1. KADCYLA (ado-trastuzumab emtansine)
2. HERCLON (Trastuzumab) 440 mg Injection

Dosage Forms and Strengths

ado-trastuzumab emtansine Biosimilar approved and marketed in India is available as Lyophilized powder in single-use vials containing 100 mg per vial or 160 mg per vial..